Pharmaceutical Industry

Page 44 of 100

House And Senate To Vote On GOP Tax Reform Plan

This Once-Free Drug for a Rare Condition Now Costs $375,000

By
February 4, 2019
infant ibuprofen recall
Retail

More Infant Ibuprofen Sold at Walmart and CVS Recalled Over Safety Concerns

By
January 31, 2019
Walgreens Reports Quarterly Earnings

Fake Walgreens Pharmacist Alleged to Have Filled 750,000 Prescriptions

By
January 31, 2019
Prescription bottles.

Net Drug Prices Are Falling, Even as List Prices Increase

By
January 30, 2019
Laboratory for production of cancer drug

WHO Suggests Cancer Drug Prices Are Too High

By
January 25, 2019
Midsection of mature male pharmacist holding prescription paper and medicine standing by drawer at store

Prescription Drug Companies Are Raising Prices on Older Medicines

By
January 18, 2019
CVS Pharmacy in New York City

Walmart Leaving the CVS Health Network Could Roil Drugstores

By
January 15, 2019
drug recall

Blood Pressure Drug Recall List Expands to Include More Valsartan Tablets

By
January 3, 2019
Laboratory for production of cancer drug

Bristol-Myers Is Buying Celgene for $74 Billion in One of the Largest Big Pharma Mergers Ever

By
January 3, 2019
drug prices

Drugmakers Celebrate the New Year by Raising Prices on Hundreds of Drugs an Average of 6.3%

By
January 2, 2019
Walgreens Posts Higher Than Expected Quarterly Earnings
Retail

Walgreens Plans on Cutting $1 Billion in Costs Over the Next Three Years

By
December 20, 2018
Paul Allen Institute for Immunology
Health

Late Microsoft Co-Founder Paul Allen’s Health Care Legacy

By
December 14, 2018
CVS Aetna prescription drug prices
Health

CVS Just Made a Big Change After Closing Its $69 Billion Aetna Deal. Here’s What That Could Mean

By
December 5, 2018
CVS Acquires Aetna For $69 Billion In Major Health Industry Deal

CVS Health Promises a New Drug Plan to Pass All Rebates Along to Consumers

By
December 5, 2018
JAPAN-IRELAND-PHARMACEUTICAL-TAKEOVER-TAKEDA-SHIRE
Health

Takeda’s Shareholders Agree to $58 Billion Shire Deal Despite Debt Fears

By
December 5, 2018

Most Popular